Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 218533
Company: ASPIRO

Products on ANDA 218533

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 218533

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/03/2024	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/18/2025	SUPPL-5	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 218533

VORICONAZOLE

POWDER;INTRAVENOUS; 200MG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
VFEND	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	021267	PF PRISM CV
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	218533	ASPIRO
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	211099	GLAND
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	208562	HIKMA
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	214516	MEITHEAL
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	090862	SANDOZ INC
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	211661	SLATE RUN PHARMA
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	211264	UBI
VORICONAZOLE	VORICONAZOLE	200MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	208983	ZYDUS PHARMS